Comparison of the efficacy between NAC and metformin in treating PCOS patients: a meta-analysis

References

• Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs. 2006;66(7):903–912.
   PubMed Web of Science ®Google Scholar
• Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59(2):141–154.
   PubMed Web of Science ®Google Scholar
• Ghandi S, Aflatoonian A, Tabibnejad N, et al. The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. J Assist Reprod Genet. 2011;28(7):591–596.
   PubMed Web of Science ®Google Scholar
• Banaszewska B, Duleba AJ, Spaczynski RZ, et al. Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol. 2006;194(5):1266–1272.
   PubMed Web of Science ®Google Scholar
• Kilicdag EB, Bagis T, Zeyneloglu HB, et al. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study. Hum Reprod. 2005;20(4):894–899.
   PubMed Web of Science ®Google Scholar
• Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ. 2003;327(7421):951–953.
   PubMed Web of Science ®Google Scholar
• Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002;77(6):1128–1135.
   PubMed Web of Science ®Google Scholar
• Rajkhowa M, Glass MR, Rutherford AJ, et al. Polycystic ovary syndrome: a risk factor for cardiovascular disease? BJOG. 2000;107(1):11–18.
   PubMedGoogle Scholar
• Ammon HP, Muller PH, Eggstein M, et al. Increase in glucose consumption by acetylcysteine during hyperglycemic clamp. A study with healthy volunteers. Arzneimittelforschung. 1992;42(5):642–645.
   PubMed Web of Science ®Google Scholar
• Soltan-Sharifi MS, Mojtahedzadeh M, Najafi A, et al. Improvement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms. Hum Exp Toxicol. 2007;26:697–703.
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):127–131.
   PubMed Web of Science ®Google Scholar
• Cheraghi E, Mehranjani MS, Shariatzadeh MA, et al. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev. 2016;28(6):723–731.
   PubMed Web of Science ®Google Scholar
• Gayatri K, Kumar J, Kumar BB. Metformin and n-acetyl cysteine in polycystic Ovarian syndrome—A comparative study. Ind J Clin Med. 2010;1:117739361000100–117739361000113.
   Google Scholar
• Maged AM, Elsawah H, Abdelhafez A, et al. The adjuvant effect of metformin andN-acetylcysteine to clomiphene citrate in induction of ovulation in patients withPolycystic Ovary Syndrome. Gynecol Endocrinol. 2015;31(8):635–638.
   PubMed Web of Science ®Google Scholar
• Elnashar A, Fahmy M, Mansour A, et al. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertil Steril. 2007;88(2):406–409.
   PubMed Web of Science ®Google Scholar
• Nemati M, Nemati S, Taheri AM, et al. Comparison of metformin and N-acetyl cysteine, as an adjuvant to clomiphene citrate, in clomiphene-resistant women with polycystic ovary syndrome. J Gynecol Obstetr Human Reprod. 2017;46(7):579–585.
   PubMed Web of Science ®Google Scholar
• Cheraghi E, Soleimani Mehranjani M, Shariatzadeh MA, et al. Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI. Int J Fertil Steril. 2014;8(2):119–128.
   PubMedGoogle Scholar
• Javanmanesh F, Kashanian M, Rahimi M, et al. A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(4):285–289.
   PubMed Web of Science ®Google Scholar
• Hashim HA, Anwar K, El-Fatah RA. N-Acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. J Women’s Health. 2010;19(11):2043–2048.
   PubMed Web of Science ®Google Scholar
• Chandil N, Pande S, Sen SS, Gupta D. Comparison of metformin and N acetylcysteine on clinical, metabolic parameter and hormonal profile in women with polycystic ovarian syndrome. J Obstet Gynecol India. 2019;69(1):77–81.
   PubMed Web of Science ®Google Scholar
• Thakker D, Raval A, Patel I, et al. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015;2015:1.
   Google Scholar
• Badawy A, State O, Abdelgawad S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet Gynecol Scand. 2007;86(2):218–222.
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Cibula D, Dvorakova K, et al. Insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:2942–2945.
   PubMed Web of Science ®Google Scholar
• Kurzawa R, Ciepiela P, Baczkowski T, et al. Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study. J Assist Reprod Genet. 2008;25(8):365–374.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu M, Ye X, et al. Delay in oocyte aging in mice by the antioxidant N-acetyl-L-cysteine (NAC). Hum Reprod. 2012;27(5):1411–1420.
   PubMed Web of Science ®Google Scholar
• Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. CPD. 2016;22(18):2709–2722.
   Web of Science ®Google Scholar
• Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 2013;40:51–63.
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Kocic R, Kocic G, et al. Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes. Diabetes Obes Metab. 2000;2(4):251–256.
   PubMed Web of Science ®Google Scholar
• Yilmaz M, Bukan N, Ayvaz G, et al. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. Hum Reprod. 2005;20(12):3333–3340.
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Bicikova M, Tallova J, et al. Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2002;110:74–76.
   PubMed Web of Science ®Google Scholar
• Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab. 2003;88(4):1723–1729.
   PubMed Web of Science ®Google Scholar
• Pieper GM, Siebeneich W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol. 1998;32(1):101–105.
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A, Zullo F, et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1–50.
   PubMed Web of Science ®Google Scholar
• Eisenhardt S, Schwarzmann N, Henschel V, et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2006;91(3):946–952.
   PubMed Web of Science ®Google Scholar